• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $STEX

    Streamex Corp.

    Subscribe to $STEX
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for Streamex Corp.

    DatePrice TargetRatingAnalyst
    See more ratings

    Streamex Corp. SEC Filings

    View All

    SEC Form 10-Q filed by Streamex Corp.

    10-Q - Streamex Corp. (0001530766) (Filer)

    11/14/25 5:28:05 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    11/6/25 5:17:54 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    11/4/25 4:31:17 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form DEFA14A filed by Streamex Corp.

    DEFA14A - Streamex Corp. (0001530766) (Filer)

    11/3/25 12:25:08 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    10/31/25 5:17:41 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    10/29/25 8:00:38 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form S-8 filed by Streamex Corp.

    S-8 - Streamex Corp. (0001530766) (Filer)

    10/3/25 5:25:11 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. (NASDAQ: STEX) Announces Launch of $100,000,000 USD GLDY Pre-Sale – A Gold-Backed Yield Generating Stablecoin Offering Institutional Yield on Physical Gold Bullion

    The launch of Streamex's $100 million USD GLDY pre-sale marks a historic opportunity for gold investors. Investing in gold is no longer just a static store of value, Streamex, through GLDY has created a yield-generating, institutional grade asset designed to offer both spot gold exposure and yield paid in additional ounces of physical gold bullion.  Key Highlights Gold Price Exposure and Gold-Denominated Distributions: GLDY is designed to combine audited physical bullion holdings with yield from institutionally managed gold leases sourced through Monetary Metals. GLDY seeks to provide exposure to the price of gold while targeting periodic distributions paid in additional ounces of gold.Rev

    11/10/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. to Participate at the Cantor Fitzgerald Crypto & AI/Energy Infrastructure Conference on November 10-12, 2025

    LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization of real-world assets, today announced Henry McPhie, CEO and Co-Founder, will participate at the Cantor Crypto & AI/Energy Infrastructure Conference, taking place on November 10-12, 2025, at The Ritz-Carlton South Beach in Miami Beach, Florida. Mr. McPhie will host one-on-one meetings with institutional investors at the conference. "Cantor Fitzgerald has established itself as a premier bridge between traditional finance and digital assets," said Henry McPhie. "This conference provides the ideal platform to connect with institutional investo

    11/6/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Gold Bullion Purchases & Closing of Initial USD $25,000,000 Tranche of the Previously Announced Financing; All Net Proceeds Deployed into Physical Gold Bullion

    LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization of real-world assets and commodity-backed stablecoins, including GLDY, today announced the closing of the first tranche of convertible debenture financing with the principal amount of USD $25,000,000 in financing as previously announced in July 2025 with a leading institutional investor. Key Transaction Highlights: All net proceeds from the financing will be allocated toward Streamex's initial purchases of Physical Allocated Gold Bullion, reinforcing Streamex's gold denominated balance sheet and Gold Per Share.Cantor, Clear Street, and Ne

    11/5/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Nasdaq Approval for Continued Listing on Nasdaq Capital Market & Shareholder Meeting on November 4, 2025

    LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), an institutional commodity tokenization company, today announced that it has received formal approval from Nasdaq for continued listing of its shares of common stock on the Nasdaq Capital Market under the ticker symbol "STEX." In conjunction with the Nasdaq approval, Streamex will convene a special meeting of shareholders at 3:00 PM EST on November 4, 2025, to reconvene the previously adjourned Proposal 1 – the Acquisition Proposal, for formal vote and approval. Shareholder Meeting The upcoming shareholder meeting will address the previously adjourned, Proposal 1 - The Acquisition

    10/30/25 5:48:42 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Enters Strategic Partnership with Chainlink as Its Official Oracle Provider to Strengthen Tokenization Infrastructure

    This strategic partnership enhances the cross-chain functionality, transparency, and trust for GLDY through the integration of Chainlink Proof of Reserves, Price Feeds, and Cross-Chain Interoperability Protocol (CCIP). GLDY is a gold backed stablecoin asset designed to deliver institutional-grade cash management and yield on physical gold holdings. Key Highlights Enhanced Transparency: Integration of Chainlink Proof of Reserve and Price Feeds for real-time, onchain verification of gold reserves backing GLDY and delivery of tamper-proof market data.Cross-Chain Interoperability: Streamex integrates Chainlink's Cross-Chain Interoperability Protocol (CCIP) initially across Base and Solana mai

    10/27/25 8:00:00 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) to Participate in the 28th Annual Needham Growth Conference

    LOS ANGELES, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a vertically integrated commodity tokenization company, today announced that members of its executive management team will participate in the 28th Annual Needham Growth Conference, to be held January 13–14, 2026, in New York City. The Company's executive leadership will host one-on-one meetings with institutional investors and present information on its yield-bearing gold backed stablecoin, GLDY, as well as other advancements and initiatives. About Streamex Corp. Streamex Corp. is a vertically integrated commodity tokenization company focused on bringing real-world assets, particul

    10/8/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Pre-Sale of Up to $100,000,000 USD for GLDY, a Gold Backed Stablecoin Asset Offering Up to 4.0% Yield

    Key Highlights Institutional Scale & Balance-Sheet Alignment: $100,000,000 USD in initial pre-sale capacity with near-term expandable issuance of up to $1.0 billion; Streamex to co-invest with a minimum $5,000,000 USD commitment, demonstrating management alignment and balance-sheet support.Institutional Grade Gold Product with Yield: GLDY is a physical bullion backed stablecoin that delivers up to 4.0% annualized yield (paid in ounces of physical gold) through gold-leasing, combining capital preservation of physical gold with predictable income.Regulated, Institutional Infrastructure: To be launched through the Streamex platform and distributed through institutional channels, GLDY is engine

    10/6/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. to Participate in the Clear Street Disruptive Technology Conference on November 19-20, 2025

    LOS ANGELES, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets, today announced the executive management team, will participate in one-to-one meetings at the Clear Street Disruptive Technology Conference at The Four Seasons Resort in Palm Beach, Florida, taking place November 19-20, 2025. "This conference represents an ideal platform to connect with institutional investors who understand that the transformative potential of real-world asset tokenization is a key innovation," said Henry McPhie, CEO and Co-Founder of Streamex Corp. About Streamex Corp.Streamex is a real-world ass

    9/29/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFs

    Key Partnership Highlights: Streamex & Simplify have entered into a letter of intent outlining a framework for pursuing a strategic partnership to leverage each other's platforms for next-generation financial products.Focus on the integration of Streamex's tokenized yield-bearing gold into ETF structures, bridging blockchain innovation with institutional-grade financial products.Distribution expansion across both partners' platforms, subject to definitive agreements and regulatory approval.Jointly intending to collaborate, subject to definitive agreements, on developing ETP/ETF offerings designed to expand investor access to regulated, liquid, and yield-generating gold and commodity-backed

    9/17/25 8:30:00 AM ET
    $BSGM
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Financials

    Live finance-specific insights

    View All

    Streamex Corp. (NASDAQ: STEX) Announces Launch of $100,000,000 USD GLDY Pre-Sale – A Gold-Backed Yield Generating Stablecoin Offering Institutional Yield on Physical Gold Bullion

    The launch of Streamex's $100 million USD GLDY pre-sale marks a historic opportunity for gold investors. Investing in gold is no longer just a static store of value, Streamex, through GLDY has created a yield-generating, institutional grade asset designed to offer both spot gold exposure and yield paid in additional ounces of physical gold bullion.  Key Highlights Gold Price Exposure and Gold-Denominated Distributions: GLDY is designed to combine audited physical bullion holdings with yield from institutionally managed gold leases sourced through Monetary Metals. GLDY seeks to provide exposure to the price of gold while targeting periodic distributions paid in additional ounces of gold.Rev

    11/10/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care